MAYNE PHARMA GROUP LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.28 AUD | -2.28% |
|
-9.13% | -30.41% |
| 02/07 | Australian Shares Slide as Central Bank Shows Signs of Possible Rate Hike | MT |
| 03/06 | Swissmedic Grants Mayne Pharma Group Expanded Kapanol Dosage Approvals in Switzerland | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 24Cr | - | |||||
| 4.51TCr | ||||||
| 2.34TCr | ||||||
| 1.61TCr | ||||||
| 1.46TCr | ||||||
| 1.4TCr |
